A Cancer Trial’s Unexpected Result: Remission in Every Patient (Published 2022)
The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.”
https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.htmlOpen linkView original on lemmy.world
This was published one year ago, and I wonder if there have been followup trials since.
Looks like this drug has multiple on going trials. Here is a phase II/III trial ongoing that's probably the direct successor to the trial in the article. It's currently recruiting, they expect to be done some time in 2025.
https://classic.clinicaltrials.gov/ct2/show/NCT05723562
Clinicaltrials.gov makes it really easy to find pretty much any trial.